{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:06:17Z","timestamp":1792757177030,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T00:00:00Z","timestamp":1703462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T00:00:00Z","timestamp":1703462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10528-023-10614-3","type":"journal-article","created":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T07:01:52Z","timestamp":1703487712000},"page":"3568-3585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Effect of Angiotensin-Converting Enzyme Insertion\/Deletion Polymorphism on the Severity and Death Rate of COVID-19 in Iranian Patients"],"prefix":"10.1007","volume":"62","author":[{"given":"Mohammad","family":"Samet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Tajamolian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Beygi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hasan","family":"Sheikhha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mehdi","family":"Hoseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,25]]},"reference":[{"issue":"Suppl 1","key":"10614_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000176939","volume":"86","author":"WT Abraham","year":"1995","unstructured":"Abraham WT et al (1995) Importance of angiotensin-converting enzyme in pulmonary hypertension. Cardiology 86(Suppl 1):9\u201315","journal-title":"Cardiology"},{"issue":"6","key":"10614_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13989","volume":"33","author":"H Aksoy","year":"2020","unstructured":"Aksoy H, Karadag AS, Wollina U (2020) Angiotensin II receptors: impact for COVID-19 severity. Dermatol Ther 33(6):e13989","journal-title":"Dermatol Ther"},{"issue":"11","key":"10614_CR3","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/jmv.26097","volume":"92","author":"N Ali","year":"2020","unstructured":"Ali N (2020) Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J Med Virol 92(11):2409\u20132411","journal-title":"J Med Virol"},{"issue":"4","key":"10614_CR4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/1470320312459976","volume":"14","author":"A Ali","year":"2013","unstructured":"Ali A et al (2013) ACE I\/D and eNOS E298D gene polymorphisms in Saudi subjects with hypertension. J Renin Angiotensin Aldosterone Syst 14(4):348\u2013353","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"2","key":"10614_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1046\/j.1523-1755.2001.059002407.x","volume":"59","author":"M Arici","year":"2001","unstructured":"Arici M, Walls J (2001) End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 59(2):407\u2013414","journal-title":"Kidney Int"},{"issue":"4","key":"10614_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.440","volume":"4","author":"F Babajani","year":"2021","unstructured":"Babajani F et al (2021) COVID-19 and renin angiotensin aldosterone system: pathogenesis and therapy. Health Sci Rep 4(4):e440","journal-title":"Health Sci Rep"},{"issue":"6","key":"10614_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1399-0004.1997.tb02562.x","volume":"52","author":"KE Berge","year":"1997","unstructured":"Berge KE, Berg K (1997) Cardiovascular risk factors in people with different genotypes in the insertion\/deletion (I\/D) polymorphism at the locus for angiotensin I-converting enzyme (ACE). Clin Genet 52(6):422\u2013426","journal-title":"Clin Genet"},{"key":"10614_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.631148","volume":"7","author":"C Calabrese","year":"2020","unstructured":"Calabrese C et al (2020) ACE gene I\/D polymorphism and acute pulmonary embolism in COVID19 pneumonia: a potential predisposing role. Front Med (lausanne) 7:631148","journal-title":"Front Med (lausanne)"},{"issue":"6","key":"10614_CR9","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3390\/cancers12061457","volume":"12","author":"MJ Catarata","year":"2020","unstructured":"Catarata MJ et al (2020) Renin-angiotensin system in lung tumor and microenvironment interactions. Cancers (Basel) 12(6):1457","journal-title":"Cancers (Basel)"},{"key":"10614_CR10","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.2c01352","author":"J Chen","year":"2022","unstructured":"Chen J et al (2022) Emerging dominant SARS-CoV-2 variants. ArXiv. https:\/\/doi.org\/10.1021\/acs.jcim.2c01352","journal-title":"ArXiv"},{"key":"10614_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2022.11.023","author":"H \u00c7obanogullari","year":"2023","unstructured":"\u00c7obanogullari H et al (2023) Strong association between angiotensin-converting enzyme gene InDel polymorphism and COVID-19 diseases. Medicina Cl\u00ednica. https:\/\/doi.org\/10.1016\/j.medcli.2022.11.023","journal-title":"Medicina Cl\u00ednica"},{"issue":"3","key":"10614_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150613","volume":"11","author":"SS de Carvalho","year":"2016","unstructured":"de Carvalho SS et al (2016) Influence of ACE I\/D polymorphism on circulating levels of plasminogen activator inhibitor 1, D-dimer, ultrasensitive c-reactive protein and transforming growth factor \u03b21 in patients undergoing hemodialysis. PLoS ONE 11(3):e0150613","journal-title":"PLoS ONE"},{"issue":"3","key":"10614_CR13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1161\/01.CIR.0000052617.91920.FD","volume":"107","author":"S Devaraj","year":"2003","unstructured":"Devaraj S, Xu DY, Jialal I (2003) C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 107(3):398\u2013404","journal-title":"Circulation"},{"issue":"4","key":"10614_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M (2020a) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8(4):e21","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10614_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M (2020b) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8(4):e21","journal-title":"Lancet Respir Med"},{"key":"10614_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.955965","volume":"13","author":"A Faridzadeh","year":"2022","unstructured":"Faridzadeh A et al (2022) The role of ACE1 I\/D and ACE2 polymorphism in the outcome of Iranian COVID-19 patients: a case-control study. Front Genet 13:955965","journal-title":"Front Genet"},{"issue":"24","key":"10614_CR17","doi-asserted-by":"publisher","first-page":"9602","DOI":"10.3390\/ijms21249602","volume":"21","author":"R Franco","year":"2020","unstructured":"Franco R et al (2020) Functional complexes of angiotensin-converting enzyme 2 and renin-angiotensin system receptors: expression in adult but not fetal lung tissue. Int J Mol Sci 21(24):9602","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10614_CR18","first-page":"24","volume":"15","author":"J Gao","year":"2000","unstructured":"Gao J et al (2000) Polymorphism of angiotensin-converting enzyme gene and genetic susceptibility to asthma with familial aggregation. Chin Med Sci J 15(1):24\u201328","journal-title":"Chin Med Sci J"},{"issue":"9","key":"10614_CR19","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/genes11091044","volume":"11","author":"D Gemmati","year":"2020","unstructured":"Gemmati D, Tisato V (2020) Genetic hypothesis and pharmacogenetics side of renin-angiotensin-system in COVID-19. Genes (Basel) 11(9):1044","journal-title":"Genes (Basel)"},{"issue":"1","key":"10614_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.21873\/invivo.12672","volume":"36","author":"I Gintoni","year":"2022","unstructured":"Gintoni I, Adamopoulou M, Yapijakis C (2022) The impact of ACE and ACE2 gene polymorphisms in pulmonary diseases including COVID-19. In Vivo 36(1):13\u201329","journal-title":"In Vivo"},{"key":"10614_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.145102","volume":"762","author":"J G\u00f3mez","year":"2020","unstructured":"G\u00f3mez J et al (2020) Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome. Gene 762:145102","journal-title":"Gene"},{"issue":"3","key":"10614_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.5144\/0256-4947.2021.141","volume":"41","author":"O Gunal","year":"2021","unstructured":"Gunal O et al (2021) Angiotensin-converting enzyme-1 gene insertion\/deletion polymorphism may be associated with COVID-19 clinical severity: a prospective cohort study. Ann Saudi Med 41(3):141\u2013146","journal-title":"Ann Saudi Med"},{"issue":"10","key":"10614_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075870","volume":"8","author":"Q He","year":"2013","unstructured":"He Q et al (2013) Associations of ACE gene insertion\/deletion polymorphism, ACE activity, and ACE mRNA expression with hypertension in a Chinese population. PLoS ONE 8(10):e75870","journal-title":"PLoS ONE"},{"issue":"6","key":"10614_CR24","doi-asserted-by":"publisher","first-page":"1702638","DOI":"10.1183\/13993003.02638-2017","volume":"51","author":"AR Hemnes","year":"2018","unstructured":"Hemnes AR et al (2018) A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension. Eur Respir J 51(6):1702638","journal-title":"Eur Respir J"},{"issue":"2","key":"10614_CR25","first-page":"4512","volume":"30","author":"SM Hoseini","year":"2022","unstructured":"Hoseini SM et al (2022) Angiotensin-converting enzymes, the key components in the pathogenesis of COVID-19 infection and their role in the interaction of SARS-Cov-2 with human host cells. J Shahid Sadoughi Univ Med Sci 30(2):4512\u20134534","journal-title":"J Shahid Sadoughi Univ Med Sci"},{"key":"10614_CR26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cca.2021.04.024","volume":"519","author":"JA Hubacek","year":"2021","unstructured":"Hubacek JA et al (2021) ACE I\/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors. Clin Chim Acta 519:206\u2013209","journal-title":"Clin Chim Acta"},{"key":"10614_CR27","doi-asserted-by":"publisher","first-page":"688071","DOI":"10.3389\/fendo.2021.688071","volume":"12","author":"M \u00cd\u00f1iguez","year":"2021","unstructured":"\u00cd\u00f1iguez M et al (2021) ACE gene variants rise the risk of severe COVID-19 in patients with hypertension, dyslipidemia or diabetes: a Spanish pilot study. Front Endocrinol 12:688071","journal-title":"Front Endocrinol"},{"issue":"5","key":"10614_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102248","volume":"15","author":"SK Jayaswal","year":"2021","unstructured":"Jayaswal SK et al (2021) Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: a multi-center case-control study from India. Diabetes Metab Syndr 15(5):102248","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"10614_CR29","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.chest.2019.04.015","volume":"156","author":"M Kreuter","year":"2019","unstructured":"Kreuter M et al (2019) Association of angiotensin modulators with the course of idiopathic pulmonary fibrosis. Chest 156(4):706\u2013714","journal-title":"Chest"},{"issue":"9","key":"10614_CR30","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/ejhg.2011.66","volume":"19","author":"X Li","year":"2011","unstructured":"Li X et al (2011) Worldwide spatial genetic structure of angiotensin-converting enzyme gene: a new evolutionary ecological evidence for the thrifty genotype hypothesis. Eur J Hum Genet 19(9):1002\u20131008","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10614_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/15412555.2012.727047","volume":"10","author":"W Li","year":"2013","unstructured":"Li W et al (2013) Angiotensin-converting enzyme I\/D polymorphism is associated with COPD risk in Asian population: evidence from a meta-analysis. COPD 10(1):35\u201339","journal-title":"COPD"},{"key":"10614_CR32","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.2147\/COPD.S168772","volume":"13","author":"Y Ma","year":"2018","unstructured":"Ma Y et al (2018) ACE gene polymorphism is associated with COPD and COPD with pulmonary hypertension: a meta-analysis. Int J Chron Obstruct Pulmon Dis 13:2435\u20132446","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"10614_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4049\/jimmunol.2000413","volume":"205","author":"RH Manjili","year":"2020","unstructured":"Manjili RH et al (2020) COVID-19 as an acute inflammatory disease. J Immunol 205(1):12\u201319","journal-title":"J Immunol"},{"issue":"9","key":"10614_CR34","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2174\/1381612033455431","volume":"9","author":"RP Marshall","year":"2003","unstructured":"Marshall RP (2003) The pulmonary renin-angiotensin system. Curr Pharm Des 9(9):715\u2013722","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10614_CR35","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1164\/rccm.2108086","volume":"166","author":"RP Marshall","year":"2002","unstructured":"Marshall RP et al (2002) Angiotensin converting enzyme insertion\/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 166(5):646\u2013650","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10614_CR36","doi-asserted-by":"publisher","first-page":"L156","DOI":"10.1152\/ajplung.00313.2002","volume":"286","author":"RP Marshall","year":"2004","unstructured":"Marshall RP et al (2004) Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol 286(1):L156\u2013L164","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10614_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211054","volume":"14","author":"HG Mengesha","year":"2019","unstructured":"Mengesha HG et al (2019) Effects of angiotensin converting enzyme gene polymorphism on hypertension in Africa: a meta-analysis and systematic review. PLoS ONE 14(2):e0211054","journal-title":"PLoS ONE"},{"issue":"11","key":"10614_CR38","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/jpm11111098","volume":"11","author":"MM Mir","year":"2021","unstructured":"Mir MM et al (2021) Strong association of angiotensin converting enzyme-2 gene insertion\/deletion polymorphism with susceptibility to SARS-CoV-2, hypertension, coronary artery disease and COVID-19 disease mortality. J Pers Med 11(11):1098","journal-title":"J Pers Med"},{"key":"10614_CR39","unstructured":"Organization, WH, Clinical management of COVID-19: living guideline, 15 September 2022. 2022, World Health Organization"},{"key":"10614_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104682","volume":"88","author":"N Pabalan","year":"2021","unstructured":"Pabalan N et al (2021) Ethnic and age-specific acute lung injury\/acute respiratory distress syndrome risk associated with angiotensin-converting enzyme insertion\/deletion polymorphisms, implications for COVID-19: a meta-analysis. Infect Genet Evol 88:104682","journal-title":"Infect Genet Evol"},{"issue":"8","key":"10614_CR41","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","volume":"118","author":"VB Patel","year":"2016","unstructured":"Patel VB et al (2016) Role of the ACE2\/angiotensin 1\u20137 axis of the renin\u2013angiotensin system in heart failure. Circ Res 118(8):1313\u20131326","journal-title":"Circ Res"},{"issue":"6","key":"10614_CR42","first-page":"869","volume":"80","author":"CS Philipp","year":"1998","unstructured":"Philipp CS et al (1998) Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty. Thromb Haemost 80(6):869\u2013873","journal-title":"Thromb Haemost"},{"issue":"1","key":"10614_CR43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12881-019-0943-3","volume":"21","author":"M Ramezani","year":"2020","unstructured":"Ramezani M, Zavattaro E, Sadeghi M (2020) Angiotensin-converting enzyme gene insertion\/deletion polymorphism and susceptibility to psoriasis: a systematic review and meta-analysis. BMC Med Genet 21(1):8","journal-title":"BMC Med Genet"},{"issue":"1","key":"10614_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/sj.ijo.0802829","volume":"29","author":"C Riera-Fortuny","year":"2005","unstructured":"Riera-Fortuny C et al (2005) The relation between obesity, abdominal fat deposit and the angiotensin-converting enzyme gene I\/D polymorphism and its association with coronary heart disease. Int J Obes (lond) 29(1):78\u201384","journal-title":"Int J Obes (lond)"},{"issue":"3","key":"10614_CR45","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jinf.2021.06.002","volume":"83","author":"S Risti\u0107","year":"2021","unstructured":"Risti\u0107 S et al (2021) ACE I\/D polymorphism and epidemiological findings for COVID-19: one year after the pandemic outbreak in Europe. J Infect 83(3):381\u2013412","journal-title":"J Infect"},{"issue":"4","key":"10614_CR46","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s40615-020-00853-0","volume":"8","author":"R Sarangarajan","year":"2021","unstructured":"Sarangarajan R et al (2021) Ethnic prevalence of angiotensin-converting enzyme deletion (D) polymorphism and COVID-19 risk: rationale for use of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers. J Racial Ethn Health Dispar 8(4):973\u2013980","journal-title":"J Racial Ethn Health Dispar"},{"issue":"4","key":"10614_CR47","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","volume":"87","author":"T Singhal","year":"2020","unstructured":"Singhal T (2020) A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 87(4):281\u2013286","journal-title":"Indian J Pediatr"},{"key":"10614_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.humgen.2022.201099","volume":"34","author":"J Soltani Rezaiezadeh","year":"2022","unstructured":"Soltani Rezaiezadeh J et al (2022) The association of ACE I\/D polymorphism with the severity of COVID-19 in Iranian patients: a case-control study. Human Gene 34:201099","journal-title":"Human Gene"},{"key":"10614_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coph.2017.12.002","volume":"40","author":"WSD Tan","year":"2018","unstructured":"Tan WSD et al (2018) Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases. Curr Opin Pharmacol 40:9\u201317","journal-title":"Curr Opin Pharmacol"},{"key":"10614_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2021.104801","volume":"91","author":"S Verma","year":"2021","unstructured":"Verma S et al (2021) Impact of I\/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients. Infect Genet Evol 91:104801","journal-title":"Infect Genet Evol"},{"issue":"8","key":"10614_CR51","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ et al (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A Review. JAMA 324(8):782\u2013793","journal-title":"JAMA"},{"issue":"7","key":"10614_CR52","doi-asserted-by":"publisher","first-page":"1921.e1","DOI":"10.1016\/j.neurobiolaging.2013.01.003","volume":"34","author":"SJ Wu","year":"2013","unstructured":"Wu SJ et al (2013) Functional regulation of Alu element of human angiotensin-converting enzyme gene in neuron cells. Neurobiol Aging 34(7):1921.e1\u20137","journal-title":"Neurobiol Aging"},{"key":"10614_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144944","volume":"758","author":"N Yamamoto","year":"2020","unstructured":"Yamamoto N et al (2020) SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I\/D genotype. Gene 758:144944","journal-title":"Gene"},{"issue":"1","key":"10614_CR54","first-page":"14","volume":"113","author":"WA Zarouk","year":"2012","unstructured":"Zarouk WA et al (2012) Association of angiotensin converting enzyme gene (I\/D) polymorphism with hypertension and type 2 diabetes. Bratisl Lek Listy 113(1):14\u201318","journal-title":"Bratisl Lek Listy"},{"issue":"2","key":"10614_CR55","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1398-9995.2010.02438.x","volume":"66","author":"YG Zhang","year":"2011","unstructured":"Zhang YG et al (2011) The I\/D polymorphism of angiotensin-converting enzyme gene and asthma risk: a meta-analysis. Allergy 66(2):197\u2013205","journal-title":"Allergy"},{"key":"10614_CR56","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fonc.2019.00044","volume":"9","author":"S Zmorzynski","year":"2019","unstructured":"Zmorzynski S et al (2019a) ACE insertion\/deletion polymorphism (rs4646994) is associated with the increased risk of multiple myeloma. Front Oncol 9:44","journal-title":"Front Oncol"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-023-10614-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-023-10614-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-023-10614-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T16:27:21Z","timestamp":1727368041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-023-10614-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,25]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10614"],"URL":"https:\/\/doi.org\/10.1007\/s10528-023-10614-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3198547\/v1","asserted-by":"object"}]},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,25]]},"assertion":[{"value":"24 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that there is no conflict of interest regarding the publication and financial issues of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All aspects of the study (blood sampling, data collection) were carried out by the principles of the Shahid Sadoughi University of Medical Sciences and Health Services guidelines. The study was approved by the <i>Ethical Committee of Medical School<\/i>, Shahid Sadoughi University of Medical Sciences and Health Services, under the permission number \u201cIR.SSU.MEDICINE.REC.1400.371\u201d.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The personal data gathered in the study are published as the whole results of the population which are not individually identifiable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}